Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? (Q43637362)

25 November 2017

0 references

Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences? (English)

1 reference

25 November 2017

0 references

Flavio Nervi

1

1 reference

25 November 2017

Marco Arrese

series ordinal

2

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2013

1 reference

The American Journal of Gastroenterology

25 November 2017

1 reference

25 November 2017

108

1 reference

25 November 2017

6

1 reference

25 November 2017

959-961

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2013.84

25 November 2017

0 references

cites work

Epidemiology of gallbladder disease: cholelithiasis and cancer

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

GI epidemiology: nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Cholesterol gallstone disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Current concepts in the pathogenesis of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Hepatic insulin resistance directly promotes formation of cholesterol gallstones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Gallstone disease is associated with increased mortality in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

EFFECT OF CHOLECYSTECTOMY ON THE ROLE OF THE GALL BLADDER IN FAT ABSORPTION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Enterohepatic circulation of bile acids after cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Routine liver biopsy to screen for nonalcoholic fatty liver disease (NAFLD) during cholecystectomy for gallstone disease: is it justified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Gallbladder disease is associated with insulin resistance in a high risk Hispanic population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Cholelithiasis, cholecystectomy, and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Role of bile acids and bile acid receptors in metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

The bile acid membrane receptor TGR5: a valuable metabolic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Bile acids as regulators of hepatic lipid and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

21 January 2018

Physiology of FGF15/19

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Transgenic Mice Expressing Human Fibroblast Growth Factor-19 Display Increased Metabolic Rate and Decreased Adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Perspective: TGR5 (Gpbar-1) in liver physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Weight gain after laparoscopic cholecystectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2013.84

21 January 2018

Identifiers

DOI

10.1038/AJG.2013.84

1 reference

Dimensions Publication ID

25 November 2017

0 references

1 reference